558 related articles for article (PubMed ID: 24356256)
1. Motavizumab treatment of infants hospitalized with respiratory syncytial virus infection does not decrease viral load or severity of illness.
Ramilo O; Lagos R; Sáez-Llorens X; Suzich J; Wang CK; Jensen KM; Harris BS; Losonsky GA; Griffin MP;
Pediatr Infect Dis J; 2014 Jul; 33(7):703-9. PubMed ID: 24356256
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of motavizumab for the prevention of respiratory syncytial virus disease in healthy Native American infants: a phase 3 randomised double-blind placebo-controlled trial.
O'Brien KL; Chandran A; Weatherholtz R; Jafri HS; Griffin MP; Bellamy T; Millar EV; Jensen KM; Harris BS; Reid R; Moulton LH; Losonsky GA; Karron RA; Santosham M;
Lancet Infect Dis; 2015 Dec; 15(12):1398-408. PubMed ID: 26511956
[TBL] [Abstract][Full Text] [Related]
3. Safety and antiviral activity of motavizumab, a respiratory syncytial virus (RSV)-specific humanized monoclonal antibody, when administered to RSV-infected children.
Lagos R; DeVincenzo JP; Muñoz A; Hultquist M; Suzich J; Connor EM; Losonsky GA
Pediatr Infect Dis J; 2009 Sep; 28(9):835-7. PubMed ID: 19636278
[TBL] [Abstract][Full Text] [Related]
4. Palivizumab prophylaxis of respiratory syncytial virus disease from 1998 to 2002: results from four years of palivizumab usage.
Romero JR
Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S46-54. PubMed ID: 12671452
[TBL] [Abstract][Full Text] [Related]
5. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group.
Pediatrics; 1998 Sep; 102(3 Pt 1):531-7. PubMed ID: 9738173
[TBL] [Abstract][Full Text] [Related]
6. Effect of dexamethasone on tracheal viral load and interleukin-8 tracheal concentration in children with respiratory syncytial virus infection.
van Woensel JB; Lutter R; Biezeveld M; Dekker T; Nijhuis M; van Aalderen WM; Kuijpers TW
Pediatr Infect Dis J; 2003 Aug; 22(8):721-6. PubMed ID: 12913774
[TBL] [Abstract][Full Text] [Related]
7. Respiratory syncytial virus genomic load and disease severity among children hospitalized with bronchiolitis: multicenter cohort studies in the United States and Finland.
Hasegawa K; Jartti T; Mansbach JM; Laham FR; Jewell AM; Espinola JA; Piedra PA; Camargo CA
J Infect Dis; 2015 May; 211(10):1550-9. PubMed ID: 25425699
[TBL] [Abstract][Full Text] [Related]
8. Relating plaque morphology to respiratory syncytial virus subgroup, viral load, and disease severity in children.
Kim YI; Murphy R; Majumdar S; Harrison LG; Aitken J; DeVincenzo JP
Pediatr Res; 2015 Oct; 78(4):380-8. PubMed ID: 26107392
[TBL] [Abstract][Full Text] [Related]
9. Azithromycin does not improve disease course in hospitalized infants with respiratory syncytial virus (RSV) lower respiratory tract disease: a randomized equivalence trial.
Kneyber MC; van Woensel JB; Uijtendaal E; Uiterwaal CS; Kimpen JL;
Pediatr Pulmonol; 2008 Feb; 43(2):142-9. PubMed ID: 18085694
[TBL] [Abstract][Full Text] [Related]
10. Respiratory syncytial virus infections in hospitalized infants: association between viral load, virus subgroup, and disease severity.
Fodha I; Vabret A; Ghedira L; Seboui H; Chouchane S; Dewar J; Gueddiche N; Trabelsi A; Boujaafar N; Freymuth F
J Med Virol; 2007 Dec; 79(12):1951-8. PubMed ID: 17935185
[TBL] [Abstract][Full Text] [Related]
11. Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus infection.
Sanders SL; Agwan S; Hassan M; van Driel ML; Del Mar CB
Cochrane Database Syst Rev; 2019 Aug; 8(8):CD009417. PubMed ID: 31446622
[TBL] [Abstract][Full Text] [Related]
12. Natural infection of infants with respiratory syncytial virus subgroups A and B: a study of frequency, disease severity, and viral load.
Devincenzo JP
Pediatr Res; 2004 Dec; 56(6):914-7. PubMed ID: 15470202
[TBL] [Abstract][Full Text] [Related]
13. Impact of severe disease caused by respiratory syncytial virus in children living in developed countries.
Simoes EA; Carbonell-Estrany X
Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S13-8; discussion S18-20. PubMed ID: 12671448
[TBL] [Abstract][Full Text] [Related]
14. Comparison of human metapneumovirus, respiratory syncytial virus and influenza A virus lower respiratory tract infections in hospitalized young children.
Wolf DG; Greenberg D; Kalkstein D; Shemer-Avni Y; Givon-Lavi N; Saleh N; Goldberg MD; Dagan R
Pediatr Infect Dis J; 2006 Apr; 25(4):320-4. PubMed ID: 16567983
[TBL] [Abstract][Full Text] [Related]
15. Hospitalization for respiratory syncytial virus bronchiolitis and disease severity in twins.
Dotan M; Ashkenazi-Hoffnung L; Samra Z; Livni G; Yarden-Bilavsky H; Amir J; Bilavsky E
Isr Med Assoc J; 2013 Nov; 15(11):701-4. PubMed ID: 24511652
[TBL] [Abstract][Full Text] [Related]
16. Nosocomial respiratory syncytial virus infections in the palivizumab-prophylaxis era with implications regarding high-risk infants.
Ashkenazi-Hoffnung L; Dotan M; Livni G; Amir J; Bilavsky E
Am J Infect Control; 2014 Sep; 42(9):991-5. PubMed ID: 25179332
[TBL] [Abstract][Full Text] [Related]
17. Respiratory syncytial virus infection in Guatemala, 2007-2012.
McCracken JP; Prill MM; Arvelo W; Lindblade KA; López MR; Estevez A; Müller ML; Muñoz F; Bernart C; Cortez M; Moir JC; Ortíz J; Paredes A; Iwane MK
J Infect Dis; 2013 Dec; 208 Suppl 3():S197-206. PubMed ID: 24265479
[TBL] [Abstract][Full Text] [Related]
18. Palivizumab outcomes registry data from Spain: Infección Respiratoria Infantil por Virus Respiratorio Sincitial (IRIS) Study Group.
Carbonell-Estrany X
Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S55-7; discussion S57. PubMed ID: 12671453
[TBL] [Abstract][Full Text] [Related]
19. Human metapneumovirus in lung transplant recipients and comparison to respiratory syncytial virus.
Hopkins P; McNeil K; Kermeen F; Musk M; McQueen E; Mackay I; Sloots T; Nissen M
Am J Respir Crit Care Med; 2008 Oct; 178(8):876-81. PubMed ID: 18658110
[TBL] [Abstract][Full Text] [Related]
20. Nebulised ALX-0171 for respiratory syncytial virus lower respiratory tract infection in hospitalised children: a double-blind, randomised, placebo-controlled, phase 2b trial.
Cunningham S; Piedra PA; Martinon-Torres F; Szymanski H; Brackeva B; Dombrecht E; Detalle L; Fleurinck C;
Lancet Respir Med; 2021 Jan; 9(1):21-32. PubMed ID: 33002427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
